Pizzutilo, E G; Agostara, A G; Oresti, S; Signorelli, D; Stabile, S; Lauricella, C; Motta, V; Amatu, A; Ruggieri, L; Brambilla, M; Occhipinti, M; Proto, C; Giusti, R; Filetti, M; Genova, C; Barletta, G; Gelsomino, F; Bennati, C; Siringo, M; Di Fazio, G R; Russano, M; Montrone, M; Gariazzo, E; Roca, E; Bordi, P; Delmonte, A; Scimone, A; Belluomini, L; Mazzoni, F; Carta, A; Pelizzari, G; Viscardi, G; Morgillo, F; Gelibter, A; Gori, S; Berardi, R; Cortinovis, D; Ardizzoni, A; Veronese, S M; Sartore-Bianchi, A; Giannetta, L G; Cerea, G; Siena, S, Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO), «ESMO OPEN», 2024, 9, Article number: 103592, pp. 1 - 10 [articolo]Open Access
Parisi, Claudia; Benitez, José Carlos; Lecourt, Hélène; Dall'Olio, Filippo Gustavo; Aldea, Mihaela; Blanc-Durand, Felix; Vergé, Véronique; Quivoron, Cyril; Naltet, Charles; Abdayem, Pamela; Lavaud, Pernelle; Ghigna, Maria Rosa; Friboulet, Luc; Loriot, Yohann; De Botton, Stéphane; Ribrag, Vincent; Ardizzoni, Andrea; Planchard, David; Soria, Jean-Charles; Barlesi, Fabrice; Besse, Benjamin, Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience, «THE JOURNAL OF LIQUID BIOPSY», 2024, 6, Article number: 100164, pp. 1 - 7 [articolo]Open Access
Bria, Emilio; Morgillo, Floriana; Garassino, Marina Chiara; Ciardiello, Fortunato; Ardizzoni, Andrea; Stefani, Alessio; Verderame, Francesco; Morabito, Alessandro; Chella, Antonio; Tonini, Giuseppe; Gilli, Marina; Del Signore, Ester; Berardi, Rossana; Mencoboni, Manlio; Bearz, Alessandra; Delmonte, Angelo; Migliorino, Marta Rita; Gridelli, Cesare; Pazzola, Antonio; Iero, Manuela; De Marinis, Filippo, Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial, «THE ONCOLOGIST», 2024, 29, pp. 690 - 698 [articolo]Open Access
Garon, Edward B.; Lu, Shun; Goto, Yasushi; De Marchi, Pedro; Paz-Ares, Luis; Spigel, David R.; Thomas, Michael; Yang, James Chih-Hsin; Ardizzoni, Andrea; Barlesi, Fabrice; Orlov, Sergey; Yoshioka, Hiroshige; Mountzios, Giannis; Khanna, Sadhvi; Bossen, Claudia; Carbini, Mariana; Turri, Sabine; Myers, Andrea; Cho, Byoung Chul, Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial, «JOURNAL OF CLINICAL ONCOLOGY», 2024, 42, pp. 180 - 191 [articolo]
Felip, Enriqueta; Metro, Giulio; Soo, Ross A; Wolf, Jürgen; Solomon, Benjamin J; Tan, Daniel Sw; Ardizzoni, Andrea; Lee, Dae Ho; Sequist, Lecia V; Barlesi, Fabrice; Ponce-Aix, Santiago; Abreu, Delvys Rodriguez; Campelo, Maria Rosario Garcia; Sprauten, Mette; Djentuh, Leslie O'Sullivan; Smith, Nathalie; Jary, Aline; Belli, Riccardo; Glaser, Sabine; Zou, Mike; Cui, Xiaoming; Giovannini, Monica; Yang, James Chih-Hsin, Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer, «EUROPEAN JOURNAL OF CANCER», 2024, 208, Article number: 114182, pp. 1 - 10 [articolo]
Di Federico, Alessandro; Angelicola, Stefania; Frascino, Mariateresa; Siracusa, Irene; Bisanti, Beatrice; Ruzzi, Francesca; Semprini, Maria Sofia; De Jonge, Hugo; De Giglio, Andrea; Sperandi, Francesca; Brocchi, Stefano; Melotti, Barbara; Giunchi, Francesca; Gruppioni, Elisa; Altimari, Annalisa; Lollini, Pier-Luigi; Ardizzoni, Andrea; Palladini, Arianna; Gelsomino, Francesco, Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations, «JCO PRECISION ONCOLOGY», 2024, 8, Article number: e2400240, pp. 1 - 9 [articolo]Open Access
De Giglio, Andrea; Leonetti, Alessandro; Comito, Francesca; Filippini, Daria Maria; Mollica, Veronica; Rihawi, Karim; Peroni, Marianna; Mazzaschi, Giulia; Ricciotti, Ilaria; Carosi, Francesca; Marchetti, Andrea; Rosellini, Matteo; Gagliano, Ambrogio; Favorito, Valentina; Nobili, Elisabetta; Gelsomino, Francesco; Melotti, Barbara; Marchese, Paola Valeria; Sperandi, Francesca; Di Federico, Alessandro; Buti, Sebastiano; Perrone, Fabiana; Massari, Francesco; Pantaleo, Maria Abbondanza; Tiseo, Marcello; Ardizzoni, Andrea, Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2024, 73, pp. 1 - 9 [articolo]Open Access
De Giglio, Andrea; Zacchini, Federico; Venturi, Giulia; Di Federico, Alessandro; Parisi, Claudia; Dall'Olio, Filippo Gustavo; Ricciotti, Ilaria; Favorito, Valentina; Gagliano, Ambrogio; De Biase, Dario; Maloberti, Thais; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Melotti, Barbara; Sperandi, Francesca; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea, Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report, «THE JOURNAL OF LIQUID BIOPSY», 2024, 6, pp. 1 - 5 [articolo]
Di Federico A.; De Giglio A.; Sperandi F.; Melotti B.; Ardizzoni A.; Gelsomino F., Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib, «ANTI-CANCER DRUGS», 2024, 35, pp. 86 - 88 [articolo]
Rossi S.; Costa R.; di Federico A.; Lo Bianco F.; D'Angelo R.; Asioli G.M.; De Giglio A.; Sperandi F.; Guarino M.; Rinaldi R.; Ardizzoni A.; Cenacchi G.; Gelsomino F., Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report, «JOURNAL OF THORACIC ONCOLOGY», 2024, 19, pp. 1352 - 1355 [articolo]
Cavazzoni A.; Salamon I.; Fumarola C.; Gallerani G.; Laprovitera N.; Gelsomino F.; Riefolo M.; Rihawi K.; Porcellini E.; Rossi T.; Mazzeschi M.; Naddeo M.; Serravalle S.; Broseghini E.; Agostinis F.; Deas O.; Roncarati R.; Durante G.; Pace I.; Lauriola M.; Garajova I.; Calin G.A.; Bonafe M.; D'Errico A.; Petronini P.G.; Cairo S.; Ardizzoni A.; Sales G.; Ferracin M., Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary, «MOLECULAR THERAPY», 2024, 32, pp. 3650 - 3668 [articolo]Open Access
Carlini, Andrea; Scarpi, Emanuela; Bettini, Carla; Ardizzoni, Andrea; Donati, Costanza Maria; Fabbri, Laura; Ghetti, Francesca; Martini, Francesca; Ricci, Marianna; Sansoni, Elisabetta; Tenti, Maria Valentina; Morganti, Alessio Giuseppe; Bruera, Eduardo; Maltoni, Marco Cesare; Rossi, Romina, Transdermal Fentanyl in Patients with Cachexia-A Scoping Review, «CANCERS», 2024, 16, Article number: 3094, pp. 1 - 16 [articolo]Open Access
Guido, Alessandra; Cuicchi, Dajana; Castellucci, Paolo; Cellini, Francesco; Di Fabio, Francesca; Llimpe, Fabiola Lorena Rojas; Strigari, Lidia; Buwenge, Milly; Cilla, Savino; Deodato, Francesco; Macchia, Gabriella; Galietta, Erika; Golfieri, Rita; Ardizzoni, Andrea; Zagari, Rocco Maurizio; Fanti, Stefano; Poggioli, Gilberto; Fuccio, Lorenzo; Morganti, Alessio G, Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2023, 50, pp. 572 - 580 [articolo]Open Access
Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco, Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors, «JTO CLINICAL AND RESEARCH REPORTS», 2023, 4, Article number: 100563, pp. 1 - 8 [articolo]Open Access
Zhou, Caicun; Solomon, Benjamin; Loong, Herbert H.; Park, Keunchil; Pérol, Maurice; Arriola, Edurne; Novello, Silvia; Han, Baohui; Zhou, Jianying; Ardizzoni, Andrea; Mak, M. Perez; Santini, Fernando C.; Elamin, Yasir Y.; Drilon, Alexander; Wolf, Jürgen; Payakachat, Nalin; Uh, Minji K.; Rajakumar, Deborah; Han, Hongmei; Puri, Tarun; Soldatenkova, Victoria; Lin, A. Bence; Lin, Boris K.; Goto, Koichi, First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2023, 389, pp. 1839 - 1850 [articolo]Open Access
